Similar Pain and Function Outcomes with PRP and Autologous Blood for Lateral Epicondylitis .
Platelet-rich Plasma or Autologous Blood Do Not Reduce Pain or Improve Function in Patients with Lateral Epicondylitis: A Randomized Controlled Trial.
Clinical orthopaedics and related research.2020 Aug;478(8):1892-1900.One hundred and nineteen patients diagnosed with lateral epicondylitis were randomized to receive either platelet rich plasma (PRP), autologous blood, or saline injections. The primary outcome of interest was pain improvement using the Visual Analogue Scale (VAS). The secondary outcomes of interest included the Disability of the Arm, Shoulder and Hand (DASH) score, grip strength, NSAID use, and amount of time taken for sick leave. All outcomes except for the use of NSAIDS and sick leave time taken were was measured at 4, 8, 12, 26, and 52 weeks post-treatment. No statistically significant differences observed between the two groups in all outcomes, at all timepoints.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
